Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,190,000 | 2,068,000 | 1,878,000 | 1,774,000 | 1,196,000 |
| Marketable Securities | 13,767,000 | 13,437,000 | 10,673,000 | 10,770,000 | 10,140,000 |
| Receivables | 8,808,000 | 10,960,000 | 5,785,000 | 6,099,000 | 6,273,000 |
| Inventories | 6,733,000 | 2,599,000 | 2,678,000 | 2,909,000 | 2,805,000 |
| Other current assets | 234,000 | 287,000 | 1,970,000 | 397,000 | 274,000 |
| TOTAL | $34,744,000 | $31,103,000 | $24,781,000 | $23,670,000 | $22,386,000 |
| Non-Current Assets | |||||
| PPE Net | 18,279,000 | 11,038,000 | 10,712,000 | 11,076,000 | 10,784,000 |
| Investments And Advances | 6,086,000 | 5,139,000 | 5,161,000 | 5,110,000 | 5,118,000 |
| Intangibles | 59,537,000 | 1,230,000 | 2,121,000 | 1,304,000 | 1,288,000 |
| Other Non-Current Assets | 5,612,000 | 4,418,000 | 3,581,000 | 3,716,000 | 2,992,000 |
| TOTAL | $89,514,000 | $21,825,000 | $21,575,000 | $21,206,000 | $20,182,000 |
| Total Assets | $124,258,000 | $52,928,000 | $46,356,000 | $44,876,000 | $42,568,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,214,000 | 9,265,000 | 8,669,000 | 10,690,000 | 8,366,000 |
| Accounts payable and accrued liabilities | 2,121,000 | 1,374,000 | 1,620,000 | 1,551,000 | 1,524,000 |
| Accrued Expenses | 1,420,000 | 947,000 | 1,084,000 | 1,004,000 | 916,000 |
| Other current liabilities | 5,333,000 | 3,635,000 | 3,448,000 | 3,280,000 | 3,141,000 |
| TOTAL | $22,157,000 | $18,754,000 | $18,555,000 | $18,401,000 | $16,317,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,710,000 | 3,713,000 | 3,140,000 | 3,118,000 | 3,072,000 |
| Other Non-Current Liabilities | 9,176,000 | 4,432,000 | 4,347,000 | 3,994,000 | 3,994,000 |
| TOTAL | $31,819,000 | $9,331,000 | $7,851,000 | $7,522,000 | $7,421,000 |
| Total Liabilities | $53,976,000 | $28,085,000 | $26,406,000 | $25,923,000 | $23,738,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,786,224 | 7,894,470 | 6,158,348 | 6,162,164 | 6,189,667 |
| Common Shares | 434,000 | 342,000 | 341,000 | 341,000 | 340,000 |
| Retained earnings | 28,923,000 | 34,908,000 | 30,243,000 | 29,099,000 | 26,742,000 |
| Other shareholders' equity | -2,239,000 | -2,935,000 | -3,661,000 | -3,335,000 | -3,985,000 |
| TOTAL | $70,282,000 | $24,843,000 | $19,950,000 | $18,953,000 | $18,830,000 |
| Total Liabilities And Equity | $124,258,000 | $52,928,000 | $46,356,000 | $44,876,000 | $42,568,000 |